LED Medical Diagnostics (LMD) Stock Price, News & Analysis

Company Overview

LED Medical Diagnostics Inc. develops and markets diagnostic dental imaging products and software in North America. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and VELscope and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides XrayVision DICOM Capture View (DCV), a dental imaging suite to capture, storage, retrieve, and view images across an entire organization; XV4 Mobile for patient follow-up and emergency use in the operating room, remote or mobile clinic, or at home; XVWeb, a Web application that allows an organization to view their images from various Web-enabled devices; and XrayVision, an open-architecture digital image management program. In addition, it offers XV Sync that enables automatic synchronization of various databases for a dental practice; DataGrabber, which allows a customer to bridge patient information from various patient management software packages to a customer's digital imaging software; DCV Data Manager, a picture archive and communication system server application; and XVLite, an open architecture digital dental x-ray software package for capturing, enhancing, and displaying dental images. Further, the company provides data mapping and database conversion services; intraoral digital radiographic sensors under the Tuxedo name; intraoral cameras; and 3D imagining hardware products under the RAYSCAN name. It serves dentists and oral health specialists. LED Medical Diagnostics Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.39 to C$0.40
• 50-Day Range: C$0.40 to C$0.40
• 52-Week Range: C$0.30 to C$0.56
• Volume: 8,500 shs
• Average Volume: 21,517 shs
• Market Capitalization: C$15.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LMD Stock Analysis - Frequently Asked Questions

How have LMD shares performed this year?

LED Medical Diagnostics' stock was trading at C$0.40 at the beginning of 2024. Since then, LMD shares have increased by 0.0% and is now trading at C$0.40.
View the best growth stocks for 2024 here.

How do I buy shares of LED Medical Diagnostics?

Shares of LMD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: CVE:LMD
• CUSIP: N/A
• CIK: N/A
• Web: www.leddental.com
• Phone: +1-604-4344614
• Fax: N/A
• Employees: 46
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 221.26
• Current Ratio: 1.32
• Quick Ratio: 1.03

Sales & Book Value

• Annual Sales: C$14.96 million
• Price / Sales: 1.04
• Cash Flow: C$0.07 per share
• Price / Cash Flow: 5.56
• Book Value: C$0.10 per share
• Price / Book: 4.08

Miscellaneous

• Outstanding Shares: 38,785,000
• Free Float: N/A
• Market Cap: C$15.51 million
• Optionable: Not Optionable
• Beta: N/A